Elena Ridloff - 11 May 2026 Form 4 Insider Report for Kymera Therapeutics, Inc. (KYMR)

Reporting relationship: Director
Issuer ticker: KYMR
Reported as of: 11 May 2026
Net transaction value: -$261,000
SEC form: 4
Accepted by SEC: 11 May 2026, 16:58:56 UTC
Prior SEC filing: 01 Apr 2026
Next SEC filing: 25 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Bruce Jacobs, as Attorney-in-Fact

Key filing fact

Elena Ridloff filed Form 4 for Kymera Therapeutics, Inc. (KYMR) on 11 May 2026.

Key facts

This page summarizes Elena Ridloff's Form 4 filing for Kymera Therapeutics, Inc. (KYMR).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 11 May 2026, 16:58.

Change

Previous filing in this sequence was filed on 01 Apr 2026.
Current net transaction value: -$261,000.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001772518 Primary reporting owner

Ridloff Elena

Relationship: Director
Address: C/O KYMERA THERAPEUTICS, INC., 500 NORTH BEACON STREET, 4TH FLOOR, WATERTOWN
Signature: /s/ Bruce Jacobs, as Attorney-in-Fact
Signature date: 11 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

KYMR transaction

Common Stock

Options Exercise

Transaction value
Shares: +3,000
Change %
Price: $31.20^*
Shares after: 3,000
Date: 11 May 2026
Ownership: Direct
Footnotes: F1

KYMR transaction

Common Stock

Sale

Transaction value: $261,000
Shares: -3,000
Change %: -100%
Price: $87.00
Shares after: 0
Date: 11 May 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

KYMR transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares: -3,000
Change %: -19%
Price: $0.000000^*
Shares after: 13,000
Date: 11 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,000
Exercise price: $31.20
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 2 footnotes

Footnote F1

These transactions were effected pursuant to a Rule 10b5-1 trading plan dated December 11, 2025 adopted by the reporting person.

Footnote F2

The shares underlying this stock option are fully vested and exercisable.